The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 49 | — | 20.1x | Near average | |
Growth | 51 | 1.8% | 5.6% | Near average | |
Quality | 35 | -379.1% | 7.6% | Near average | |
Safety | 26 | 1.5x | 0.4x | Below average | |
Capital Return | 35 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Sight Sciences, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Sight Sciences, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Sight Sciences stock has seen a gradual improvement in the average price target over the past thirty days, with the consensus rising by 3.41% to reach $10, reflecting a significant valuation gap compared to the current price ($4.34). There is a notable divergence among analysts (between $8 and $12), indicating uncertainty regarding the speed of restoring profitability despite general optimism about growth.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.